1. Prioritisation of treatment goals among older patients with non-curable cancer: the OPTion randomised controlled trial in Dutch primary care

   Stegmann, M. E., Brandenbarg, D., Reyners, A. K., van Geffen, W. H., Hiltermann, T. J. N. & Berendsen, A. J., 1-Jun-2020, In : British Journal of General Practice.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch® and ISET

   Tamminga, M., Andree, K. C., Hiltermann, T. J. N., Jayat, M., Schuuring, E., van den Bos, H., Spierings, D. C. J., Lansdorp, P. M., Timens, W., Terstappen, L. W. M. M. & Groen, H. J. M., 7-Apr-2020, In : Cancers. 12, 4

   Research output: Contribution to journal › Article › Academic › peer-review

3. Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica

   van der Geest, K. S. M., Sandovici, M., Rutgers, A., Hiltermann, T. J. N., Oosting, S. F., Slart, R. H. J. A. & Brouwer, E., 2-Apr-2020, In : Annals of the Rheumatic Diseases.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Lack of Conventional Acinar Cells in Parotid Salivary Gland of Patient Taking an Anti-PD-L1 Immune Checkpoint Inhibitor

   Pringle, S., Vegt, van der, B., Wang, X., Bakelen, van, N., Hiltermann, J., Spijkervet, F. K. L., Vissink, A., Kroese, F. G. M. & Bootsma, H., 2020, In : Frontiers in Oncology. 10, 420.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non-Small-Cell Lung Cancer With Rare or Complex Mutational Profiles

   Koopman, B., van der Wekken, A. J., Elst, ter, A., Hiltermann, J., Vilacha, J. F., Groves, M., van den Berg, A., Hiddinga, B., Hijmering-Kappelle, L., Stigt, J. A., Timens, W., Groen, H. J. M., Schuuring, E. & Kempen, van, L., 23-Apr-2020, In : JCO Precision Oncology. 4, p. 393-410 18 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (91) »

1. Treatment, pharmacological and non-pharmacological of lung cancer

   Jeroen Hiltermann (Invited speaker)

   22-Jun-2018

   Activity: Talk or presentation › Professional

2. Behandeling van Immunotherapie gerelateerde bijwerkingen met nadruk op de immuun gerelateerde pneumonitis

   Jeroen Hiltermann (Invited speaker)

   18-Sep-2018

   Activity: Talk or presentation › Professional

3. WCLC Toronto 2019

   Jeroen Hiltermann (Participant)

   22-Sep-2018 → 29-Sep-2018

   Activity: Participating in or organising an event › Participation in conference › Professional

View all (27) »